Showing results (91-100 of 97) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
BMC Cancer|September 15, 2020
Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trialBastiaan M Privé, Marcel J R Janssen, Inge M van Oort, et al.British Journal of Cancer|November 1, 2025
Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-studyIris S H Kloots, Peter H J Slootbeek, Sofie H Tolmeijer, et al.The Lancet. Oncology|April 2, 2026
[177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 studyBastiaan M Privé, Walter Noordzij, Constantijn H J Muselaers, et al.Trials|November 5, 2021
Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trialBastiaan M Privé, Marcel J R Janssen, Inge M van Oort, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 31, 2023
PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory StudySanne A M van Lith, Ilanah J Pruis, Nelleke Tolboom, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2021
Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot StudyBastiaan M Privé, Steffie M B Peters, Constantijn H J Muselaers, et al.Nature Communications|February 23, 2024
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trialKalijn F Bol, Gerty Schreibelt, Martine Bloemendal, et al.Pageof 10